Results 71 to 80 of about 390,971 (277)

Practice‐Level Variation in Outpatient Cardiac Care and Association With Outcomes

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2016
BackgroundUtilization of cardiac services varies across regions and hospitals, yet little is known regarding variation in the intensity of outpatient cardiac care across cardiology physician practices or the association with clinical endpoints, an area ...
Jeffrey D. Clough, Rahul Rajkumar, Matthew T. Crim, Lesli S. Ott, Nihar R. Desai, Patrick H. Conway, Sha Maresh, Daver C. Kahvecioglu, Harlan M. Krumholz   +8 more
doaj   +1 more source

Essential work, invisible workers: The role of digital curation in COVID‐19 Open Science

Journal of the Association for Information Science and Technology, Volume 76, Issue 4, Page 703-717, April 2025.
Abstract In this paper, we examine the role digital curation practices and practitioners played in facilitating open science (OS) initiatives amid the COVID‐19 pandemic. In Summer 2023, we conducted a content analysis of available information regarding 50 OS initiatives that emerged—or substantially shifted their focus—between 2020 and 2022 to address ...
Irene V. Pasquetto, Amina A. Abdu, Natascha Chtena   +2 more
wiley   +1 more source

Prescription Drug Coverage and Elderly Medicare Spending [PDF]

The introduction of Medicare Part D has generated interest in the cost of providing drug coverage to the elderly. Of paramount importance -- often unaccounted for in budget estimates -- are the salutary effects that increased prescription drug use might ...
Baoping Shang, Dana P. Goldman
core  

Status of oncology drugs with a conditional approval: A cross‐sectional comparison of the Food and Drug Administration and Health Canada

British Journal of Clinical Pharmacology, EarlyView.
Aims This study looks at the status of the same drugs conditionally approved by the Food and Drug Administration and Health Canada for the same oncology indication. Methods Lists of oncology drugs with a conditional approval from the Food and Drug Administration and Health Canada were generated and drug pairs with the same indication were matched ...
Joel Lexchin
wiley   +1 more source

Medicare Reimbursement for Total Joint Arthroplasty: The Driving Forces. [PDF]

, 2016
BACKGROUND: Total joint arthroplasty is a large and growing part of the U.S. Medicare budget, drawing attention to how much providers are paid for their services. The purpose of this study was to examine the variables that affect total joint arthroplasty
Howley, Michael, Padegimas, Eric M., Purtill, James J., Rothman, Richard H., Verma, Kushagra, Zmistowski, Benjamin   +5 more
core   +1 more source

Current evidence and insights on single vs. double dose of basiliximab in adult solid organ transplant recipients: A systematic review

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim The aim of this systematic review was to assess all available clinical data regarding the use of a single dose of basiliximab in solid organ transplantation compared to the standard double dosage, with particular interest in efficacy, safety and cost‐savings.
Alessio Provenzani, Braidon A. Lape, Anneliese M. Harp, Victoria Weisbrod, Lavinia Piazza   +4 more
wiley   +1 more source

Genotypic spectrum and prevalence of HPV associated with cervical cancer in Palestine

BMC Infectious Diseases
Background Cervical cancer remains a significant global public health issue, primarily driven by persistent infection with Human Papillomavirus (HPV).
Ibrahim Salhi, Mahmoud Alzahayqa, Walaa Qrei, Tarteel Qawasmi, Mohammad Qadi, Zaidoun Salah   +5 more
doaj   +1 more source

The Ryan Medicare Plan: Winners and Losers [PDF]

, 2011
Representative Paul Ryan's proposed 2012 budget has been lauded as a path to prosperity, with much attetion given to his overhaul of the medicare system. Using data from the CBO analysis of the Ryan plan, this issue brief demonstrates that any savings to
David Rosnick, Dean Baker
core  

Trends in the utilization, expenditure and costs of noninsulin glucose‐lowering drugs in the Medicaid population: Steady increases in glucagon‐like peptide‐1 receptor agonist and sodium–glucose transporter‐2 inhibitor use, prices and expenditure

British Journal of Clinical Pharmacology, EarlyView.
Aims This study aimed to analyse changes in the utilization, expenditure and average cost of noninsulin glucose‐lowering drugs (GLDs) between 2008 and 2023. Methods This was a retrospective observational study of 2008–2023 data from the National Medicaid State Drug Utilization database.
Rawan O. Almadfaa
wiley   +1 more source

The Freedom to Spend Your Own Money on Medical Care: A Common Casualty of Universal Coverage [PDF]

, 2007
Most people would agree that a patient should always be able to spend his own money on the health care services he desires. Yet that freedom is often threatened or denied when government tries to provide universal health insurance coverage, as in the U.S.
Kent Masterson Brown
core